Tekla Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $15.8M | Buy |
173,248
+38,124
| +28% | +$3.47M | 0.62% | 43 |
|
|
2023
Q1 | $8.91M | Buy |
135,124
+68,698
| +103% | +$4.53M | 0.34% | 61 |
|
|
2022
Q4 | $3.43M | Sell |
66,426
-199,650
| -75% | -$10.3M | 0.13% | 89 |
|
|
2022
Q3 | $18.2M | Sell |
266,076
-46,116
| -15% | -$3.15M | 0.74% | 38 |
|
|
2022
Q2 | $14.1M | Buy |
312,192
+116,372
| +59% | +$5.26M | 0.55% | 52 |
|
|
2022
Q1 | $9.95M | Hold |
195,820
| – | – | 0.35% | 61 |
|
|
2021
Q4 | $9.26M | Hold |
195,820
| – | – | 0.3% | 74 |
|
|
2021
Q3 | $6.45M | Buy |
195,820
+43,282
| +28% | +$1.43M | 0.21% | 94 |
|
|
2021
Q2 | $9.64M | Hold |
152,538
| – | – | 0.31% | 83 |
|
|
2021
Q1 | $6.55M | Sell |
152,538
-63,479
| -29% | -$2.72M | 0.23% | 103 |
|
|
2020
Q4 | $12.4M | Hold |
216,017
| – | – | 0.43% | 68 |
|
|
2020
Q3 | $6.52M | Buy |
216,017
+42,523
| +25% | +$1.28M | 0.24% | 90 |
|
|
2020
Q2 | $5.67M | Hold |
173,494
| – | – | 0.22% | 93 |
|
|
2020
Q1 | $4.65M | Buy |
173,494
+42,495
| +32% | +$1.14M | 0.21% | 90 |
|
|
2019
Q4 | $4.01M | Buy |
130,999
+32,215
| +33% | +$986K | 0.15% | 125 |
|
|
2019
Q3 | $2.38M | Buy |
+98,784
| New | +$2.38M | 0.1% | 129 |
|